Influence of body weight on the natural history and the therapeutic approaches of type 1 diabetes;Influence du poids corporel sur l'histoire naturelle et les approches thérapeutiques du diabète de type 1

Revue Medicale de Liege

Volumn 67, Issue 9, 2012, Pages 461-467

  Franck, M ^a   Paquot, N ^a   Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Autoimmunity; Body mass index; Double diabetes; Metabolic syndrome; Obesity; Type 1 diabetes; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BARIATRIC SURGERY; BODY WEIGHT; CARDIOVASCULAR RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; MEDICAL HISTORY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROGNOSIS;

ADOLESCENT; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 84867124241     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Scheen AJ, Van Gaal LF. - Le diabète de type 2 au cœur du syndrome métabolique : plaidoyer pour une prise en charge globale. Rev Med Liège, 2005, 60, 566-571. (Pubitemid 40941544)
2. Pozzilli P, Guglielmi C, Pronina E, Petraikina E. - Double diabetes : a mixture of type 1 and type 2 diabetes in youth. Endocr Dev, 2009, 14, 151-166.
3. Kibirige M, Metcalf B, Renuka R, et al. - Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care, 2003, 26, 2865-2870. (Pubitemid 37205560)
4. Verbeeten KC, Elks CE, Danemant D, et al. - Association between childhood obesity and subsequent type 1 diabetes : a systematic review and meta-analysis. Diabetic Med, 2010, 28, 10-18.
5. Dabelea D, D'Agostino RB, Mayer-Davis EJ, et al. - Testing the accelerator hypothesis: body size, β-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care, 2006, 29, 290-294. (Pubitemid 44106506)
6. Weets I, De Leeuw IH, Du Caju MV, et al. - The incidence of type 1 diabetes in the age Group 0-39 years has not increased in Antwerpen between 1989 and 2000. Diabetes Care, 2002, 25, 840-846. (Pubitemid 41094280)
7. Hyppönen E, Virtanen SM, Kenward MG, et al., and Childhood Diabetes in Finland Study Group. - Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care, 2000, 23, 1755-1760.
8. Badaru A, Pihoker C. - Type 2 diabetes in childhood: clinical characteristics and role of β-cell autoimmunity. Curr Diab Rep, 2012, 12, 75-81.
9. Zeitler P. - Approach to the obese adolescent with new-onset diabetes. J Clin Endocrinol Metab, 2010, 95, 5163-5170.
10. Nambam B, Aggarwal S, Jain A. - Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity. World J Diabetes, 2010, 1, 111-115.
11. Gale E.A.M. - Declassifying diabetes. Diabetologia, 2006, 49, 1989-1995.
12. Wikin TJ. - Changing perspectives in diabetes : their impact on its classification. Diabetologia, 2007, 50, 1587-1592.
13. Wilkin TJ. - The convergence of type 1 and type 2 diabetes in childhood, the accelerator hypothesis. Pediatr Diabetes, 2012, 13, 327-332.
14. Wilkin TJ. - The accelerator hypothesis : weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia, 2001, 44, 914-922. (Pubitemid 32642465)
15. Gale EAM. - To boldly go-or to go too boldly? The accelerator hypothesis revisited. Diabetologia, 2007, 50, 1571-1575. (Pubitemid 47036666)
16. Mannucci E, Rotella F, Ricca V, et al. - Eating disorders in patients with type 1 diabetes : a meta-analysis. J Endocrinol Invest, 2005, 28, 417-419. (Pubitemid 43162737)
17. Polonsky WH, Anderson BJ, Lohrer PA, et al. - Insulin omission in women with IDDM. Diabetes Care, 1994, 17, 1178-1185.
18. Meltzer LJ, Bennett Johnson S, Prine JM, et al. - Disordered eating, body mass, and glycemic control in adolescents with type 1 diabetes. Diabetes Care, 2001, 24, 678-682. (Pubitemid 32888848)
19. Rydall AC, Rodin GM, Olmsted MP, et al. - Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med, 1997, 336, 1849-1854. (Pubitemid 27263971)
20. Goebel-Fabbri AE, Fikkan J, Franko DL, et al. - Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care, 2008, 31, 415-419.
21. Larranaga A, Docet MF, Garcia-Mayor RV. - Disordered eating behaviors in type diabetic patients. World J Diabetes, 2011, 2, 189-195.
22. The DCCT Research Group. - The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
23. The DCCT Research Group. - Weight gain associated with intensive therapy in the diabetes control and complications trial. Diabetes Care, 1988, 11, 567-573.
24. Purnell JQ, Hokanson JE, Marcovina SM, et al. - Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. Results from the DCCT. JAMA, 1998, 280, 140-146. (Pubitemid 28498385)
25. Thorn ML, Forsblom C, Wadén J, et al. for the Finnish Diabetic Nephropathy (FinnDiane) Study Group. - Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care, 2009, 32, 950-952.
26. Kilpatrick ES, Rigby AS, Atkin SL. - Insulin resistance, the metabolic syndrome, and complication risk in Type 1 diabetes: "Double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care, 2007, 30, 707-712. (Pubitemid 46354357)
27. Nadeau KJ, Regensteiner JG, Bauer TA, et al. - Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab, 2010, 95, 513-521.
28. Esser N, Paquot N, Scheen AJ. - «Fitness» versus «fatness» : impacts cardio-métaboliques respectifs aux différents âges de la vie. Rev Med Liège, 2010, 65, 199-205.
29. Nathan DM, Cleary PA, Backlund JY, et al. - Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Eng J Med, 2005, 353, 2643-2653. (Pubitemid 41817713)
30. Davis TME, Bruce DG, Davis WA. - Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes : the Fremanthle diabetes study. Diabetes Res Clin Pract, 2007, 78, 412-417. (Pubitemid 350030323)
31. Abdelghaffar S, Attia AM. - Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents. Cochrane Database Syst Rev, 2009, 21(1), CD006691.
32. Vella S, Buetow L, Royle P, et al. - The use of metformin in type 1 diabetes : a systematic review of efficacy. Diabetologia, 2010, 53, 809-820.
33. Strowig SM, Raskin P. - The effect of rosiglitazone on overweight subjects with type 1 diabetes. Diabetes Care, 2005, 28, 1562-1567. (Pubitemid 40923065)
34. Zdravkovic V, Hamilton JK, Daneman D, et al. - Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes. J Pediatrics, 2006, 149, 845-849.
35. Scheen AJ. - Le glucagon-like peptide-1 (GLP-1), nouvelle cible dans le traitement du diabète de type 2. Rev Med Liège, 2007, 62, 216-219.
36. Sheffield CA, Kane MP, Busch RS. - Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection. Pharmacotherapy, 2007, 27, 1449-1455. (Pubitemid 47530451)
37. Varanasi A, Bellini N, Rawal D, et al. - Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol, 2011, 165, 77-84.
38. Ellis SL, Moser EG, Snell-Bergeon JK, et al. - Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes : a pilot, double-blind, randomized, crossover trial. Diabet Med, 2011, 28, 1176-1181.
39. Scheen AJ, DeFlines J, Paquot N, et al. - La chirurgie métabolique, vers une (r)évolution de la chirurgie bariatrique? Rev Med Liège, 2011, 66, 183-190.
40. De Flines J, Franck M, Rorive M, et al. - Chirurgie métabolique : une place croissante dans le traitement du diabète. Rev Med Suisse, 2012, 8, sous presse.
41. Czupryniak L, Wiszniewski M, Szymanski D, et al. - Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg, 2010, 20, 506-508.
42. Hussain A, Mahmood H, EL-Hasani S, et al. - Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg, 2009, 52, 269-275.
43. Deitel M. - Slow-progression, autoimmune, type 1 diabetes in adults : a cause of failure of resolution of diabetes after bariatric surgery. Surg Obes Relat Dis, 2009, 5, 705-706.
44. Scheen AJ, Bourguignon JP, Guillaume M. - L'éducation thérapeutique : une solution pour vaincre l'inertie clinique et le défaut d'observance. Rev Med Liège, 2010, 65, 250-255.